Wyeth Pharmaceuticals Development Pipeline

Wyeth's R&D pipeline includes novel candidate medicines across our three platforms—small molecules, vaccines, and biopharmaceuticals.  Many of these candidate medicines have the potential to be first-in-class, best-in-class, and/or first-in-therapy.  To view our development pipeline, please click here.

242230-01